Altimmune, Inc. (ALT)

5.39 +0.77 (+16.67%) USD  |  NASDAQ  |  Jan 22, 16:00
5.51 +0.12 (+2.23%) After-Hours: 04:30
More

Altimmune Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Viking Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Actinium Pharmaceuticals, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Seres Therapeutics, Inc. Upgrade